Net Income (Loss) Attributable to Parent in USD of XBiotech Inc. from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
XBiotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2013 to Q3 2025.
  • XBiotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $-6,008,000, a 19.8% decline year-over-year.
  • XBiotech Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $-29,156,000, a 10.7% increase year-over-year.
  • XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $-38,531,000, a 56.9% decline from 2023.
  • XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $-24,557,000, a 25.4% increase from 2022.
  • XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $-32,900,000, a 88.9% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

XBiotech Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $-29,156,000 $-6,008,000 -$993,000 -20% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $-28,163,000 $-1,756,000 +$11,250,000 +86% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $-39,413,000 $-10,884,000 -$882,000 -8.8% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $-38,531,000 $-10,508,000 -$5,873,000 -127% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q3 2024 $-32,658,000 $-5,015,000 +$2,349,000 +32% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $-35,007,000 $-13,006,000 -$4,264,000 -49% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $-30,743,000 $-10,002,000 -$6,186,000 -162% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $-24,557,000 $-4,635,000 -$1,432,000 -45% 01 Oct 2023 31 Dec 2023 10-K 15 Mar 2024 2023 FY
Q3 2023 $-23,125,000 $-7,364,000 +$5,294,000 +42% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $-28,419,000 $-8,742,000 +$2,902,000 +25% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $-31,321,000 $-3,816,000 +$1,579,000 +29% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $-32,900,000 $-3,203,000 +$3,264,000 +50% 01 Oct 2022 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 $-36,164,000 $-12,658,000 -$9,397,000 -288% 01 Jul 2022 30 Sep 2022 10-K 15 Mar 2024 2023 FY
Q2 2022 $-26,767,000 $-11,644,000 -$6,526,000 -128% 01 Apr 2022 30 Jun 2022 10-K 15 Mar 2024 2023 FY
Q1 2022 $-20,241,000 $-5,395,000 -$2,827,000 -110% 01 Jan 2022 31 Mar 2022 10-K 15 Mar 2024 2023 FY
Q4 2021 $-17,414,000 $-6,467,000 -$4,629,000 -252% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $-12,785,000 $-3,261,000 -$735,000 -29% 01 Jul 2021 30 Sep 2021 10-K 15 Mar 2023 2022 FY
Q2 2021 $-12,050,000 $-5,118,000 +$1,726,000 +25% 01 Apr 2021 30 Jun 2021 10-K 15 Mar 2023 2022 FY
Q1 2021 $-13,776,000 $-2,568,000 -$2,554,000 01 Jan 2021 31 Mar 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $-11,222,000 $-1,838,000 -$688,333,000 -100% 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $677,111,000 $-2,526,000 +$3,624,000 +59% 01 Jul 2020 30 Sep 2020 10-K 15 Mar 2022 2021 FY
Q2 2020 $673,487,000 $-6,844,000 -$992,000 -17% 01 Apr 2020 30 Jun 2020 10-K 15 Mar 2022 2021 FY
Q1 2020 $674,479,000 $-14,000* +$5,850,000 01 Jan 2020 31 Mar 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $668,629,000 $686,495,000 +$692,606,000 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $-23,977,000 $-6,150,000 -$1,099,000 -22% 01 Jul 2019 30 Sep 2019 10-K 16 Mar 2021 2020 FY
Q2 2019 $-22,878,000 $-5,852,000 +$55,000 +0.93% 01 Apr 2019 30 Jun 2019 10-K 16 Mar 2021 2020 FY
Q1 2019 $-22,933,000 $-5,864,000 -$1,795,000 -44% 01 Jan 2019 31 Mar 2019 10-K 16 Mar 2021 2020 FY
Q4 2018 $-21,138,000 $-6,111,000 +$1,138,000 +16% 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 $-22,276,000 $-5,051,000 +$1,154,000 +19% 01 Jul 2018 30 Sep 2018 10-K 16 Mar 2020 2019 FY
Q2 2018 $-23,430,000 $-5,907,000 +$3,226,000 +35% 01 Apr 2018 30 Jun 2018 10-K 16 Mar 2020 2019 FY
Q1 2018 $-26,656,000 $-4,069,000 +$6,494,000 +61% 01 Jan 2018 31 Mar 2018 10-K 16 Mar 2020 2019 FY
Q4 2017 $-33,150,000 $-7,249,000 +$9,149,000 +56% 01 Oct 2017 31 Dec 2017 10-K/A 15 Mar 2019 2018 FY
Q3 2017 $-42,299,000 $-6,205,000 +$6,279,000 +50% 01 Jul 2017 30 Sep 2017 10-K/A 15 Mar 2019 2018 FY
Q2 2017 $-48,578,000 $-9,133,000 +$4,489,000 +33% 01 Apr 2017 30 Jun 2017 10-K/A 15 Mar 2019 2018 FY
Q1 2017 $-53,067,000 $-10,563,000 -$306,000 -3% 01 Jan 2017 31 Mar 2017 10-K/A 15 Mar 2019 2018 FY
Q4 2016 $-52,761,000 $-16,398,000 -$4,509,000 -38% 01 Oct 2016 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 $-48,252,000 $-12,484,000 -$1,748,000 -16% 01 Jul 2016 30 Sep 2016 10-K 16 Mar 2018 2017 FY
Q2 2016 $-46,504,000 $-13,622,000 -$6,878,000 -102% 01 Apr 2016 30 Jun 2016 10-K 16 Mar 2018 2017 FY
Q1 2016 $-39,626,000 $-10,257,000 -$2,143,000 -26% 01 Jan 2016 31 Mar 2016 10-K 16 Mar 2018 2017 FY
Q4 2015 $-37,483,000 $-11,889,000 -$5,537,000 -87% 01 Oct 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
Q3 2015 $-31,946,000 $-10,736,000 -$3,773,000 -54% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $-28,173,000 $-6,744,000 -$2,838,000 -73% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016 2016 Q2
Q1 2015 $-25,335,000 $-8,114,000 -$3,611,000 -80% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
Q4 2014 $-21,724,000 $-6,352,000 01 Oct 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
Q3 2014 $-6,963,000 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2015 Q3
Q2 2014 $-3,906,000 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $-4,503,000 01 Jan 2014 31 Mar 2014 10-Q 18 Jun 2015 2015 Q1

XBiotech Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $-38,531,000 -$13,974,000 -57% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
2023 $-24,557,000 +$8,343,000 +25% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $-32,900,000 -$15,486,000 -89% 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024 2023 FY
2021 $-17,414,000 -$6,193,000 -55% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $-11,221,000 -$679,850,000 -102% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $668,629,000 +$689,767,000 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY
2018 $-21,138,000 +$12,012,000 +36% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2021 2020 FY
2017 $-33,150,000 +$19,611,000 +37% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $-52,761,000 -$15,278,000 -41% 01 Jan 2016 31 Dec 2016 10-K/A 15 Mar 2019 2018 FY
2015 $-37,483,000 -$15,759,000 -73% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
2014 $-21,724,000 -$11,797,000 -119% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $-9,927,000 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.